Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service
June 07, 2018 07:00 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic...
Fluidigm Releases Sample Identification Genotyping Panel for Translational and Clinical Research
June 05, 2018 06:30 ET
|
Fluidigm Corporation
SOUTH SAN FRANCISCO, Calif., June 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of the Advanta™ Sample ID Genotyping Panel for the identification...